Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Synergistic effect of FOXM1 an...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Synergistic effect of FOXM1 and BCL-2 inhibition in a preclinical treatment study on multiple myeloma

Synergistic effect of FOXM1 and BCL-2 inhibition in a preclinical treatment study on multiple myeloma

Bibliographic Details
Main Authors: Vivian Zhou, Manya Yu, Jiaqi Fu, Siegfried Janz, Xing Cui
Format: Article
Language:English
Published: BMC 2024-07-01
Series:Journal of Translational Medicine
Online Access:https://doi.org/10.1186/s12967-024-05452-9
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://doi.org/10.1186/s12967-024-05452-9

Similar Items

  • Upregulation of FOXM1 leads to diminished drug sensitivity in myeloma
    by: Chunyan Gu, et al.
    Published: (2018-11-01)
  • Preclinical evaluation of the simultaneous inhibition of MCL-1 and BCL-2 with the combination of S63845 and venetoclax in multiple myeloma
    by: Esperanza M Algarín, et al.
    Published: (2020-03-01)
  • Histone deacetylase inhibition in combination with MEK or BCL-2 inhibition in multiple myeloma
    by: Vijay G. Ramakrishnan, et al.
    Published: (2019-10-01)
  • PB2082: BONE MORPHOGENIC PROTEIN-6 PROMOTES THE PROLIFERATION AND INHIBITS APOPTOSIS IN MULTIPLE MYELOMA
    by: Jiaqi Fu, et al.
    Published: (2023-08-01)
  • A Review of The Synergistic Effects of Curcumin with Proteasome Inhibitors in Multiple Myeloma Preclinical Models
    by: Shaunak K. Pandya MD, et al.
    Published: (2023-03-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs